倒置大隐静脉旁路术重建缺血下肢循环的价值

笔者对 1 8例下肢动脉硬化闭塞症患者采用倒置大隐静脉旁路架桥术重建下肢血液供应。术后 2～ 36个月随访结果显示 ,1 8例术后缺血症状均消失 ,踝肱指数均值由 0 .53升为 0 .89,其中 1 2例术后可扪及静脉移植物搏动 ,严重缺血肢体挽救率 1 0 0 % ,术后 1～ 3年移植血管累计通畅率分别为 94% (1 7/1 8) ,89% (1 6/ 1 8)和 78% (1 4 / 1 8)。提示倒置大隐静脉旁路术是治疗下肢动脉硬化闭塞症的合理手术方式。选择合适的流入道血管 ,积极改善流出道条件 ,增加血流量和血流压力 ,对保证手术疗效及维持血管长期通畅具有重要意义     

自体大隐静脉原位移植术在下肢动脉硬化闭塞症的应用

目的探讨自体大隐静脉原位移植术治疗下肢动脉硬化闭塞症的效果。方法对50例下肢动脉硬化闭塞症患者(50条肢体)行自体大隐静脉原位移植术。回顾分析患者的临床资料。结果本组2例患者于移植后第4天移植血管血栓形成,急诊置管溶栓后血栓溶解,随访3年复查彩超或CTA证实移植血管血运良好。50例患者术后均获得12～24个月随访,除4例高龄患者于术后1年后截肢外,其余患者下肢疼痛明显减轻。踝肱平均指数较术前明显升高。结论自体大隐静脉原位移植术治疗下肢动脉硬化闭塞症效果肯定。     

原位大隐静脉动脉旁路术治疗下肢动脉硬化闭塞症

作者对１９８９年～１９９４年运用自制瓣膜切除器开展原位大隐静脉动脉旁路术治疗下肢动脉硬化闭塞症２８例共３０条肢体的方法、疗效和治疗体会进行了总结。患者术前踝肱指数（ＡＢＩ）为０～０．５７（平均０．４１），均经动脉造影证实。术后移植物均可扪及搏动，有１８条肢体恢复足背或胫后动脉搏动。１７例同时行输入或输出道动脉重建术。溃疡清创术６例。３例于术后３天内出现移植物搏动消失，行第二次重建术。治疗结果，ＡＢＩ平均值由术前的０．４１上升至０．８４，严重缺血肢体挽救率为１００％。术后随访，经寿命表统计分析，１～５年的血管累积通畅率分别为９２％、８８％、８６％、７８％和７１％。作者认为，原位大隐静脉动脉旁路术是治疗下肢动脉硬化闭塞症的理想方法之一，同时行输入或输出道动脉重建术，对保证移植血管的通畅有着重要的意义。     

小隐静脉原位旁路术治疗下肢动脉缺血症

为探讨下肢动脉缺血症旁路重主新的移植材料,笔者于１９９２年５月至１９９７年５月,应用小隐静脉原位旁路术治疗下肢动脉闭塞严重缺血症１８例２４条肢体并监测随访１－５年。结果：１８例近期缺血症状均显著改善,临床有效率达８８．８％,远期疗效优良率达８３．３％,经寿命青法统计分析,移植物１,３,５年通畅率分别为９５．８％,７９．６％和７０．０％,认为以小隐静脉移植材料重建因肢体循环具有不受长度限制,我需预破     

应用显微外科技术治疗广泛性下肢动脉硬化性闭塞

目的 探讨下肢广泛动脉硬化性闭塞造成的肢体缺血显微外科治疗的临床效果。方法 1998年5月～2003年1月，应用显微外科技术，采用自体长段大隐静脉逆转移植重建血供12例。结果 术后随访3个月～4年，术前的肢体冷与麻木、静息痛和间歇性跛行消失。结论 应用显微外科技术，进行大隐静脉逆转移植及动脉搭桥或静脉动脉化治疗下肢动脉硬化性闭塞，术后可获得良好的远期通畅率及较好的临床效果。     

大隐静脉原位转流术重建下肢血液循环

目的:评价大隐静脉原位转流术治疗下肢动脉硬化闭塞症的疗效.方法:运用自制瓣膜切除器开展大隐静脉原位转流术治疗下肢动脉硬化闭塞症38例共40例肢体.患者术前踝肱指数(ABI)为0-0.58(平均0.29),均经动脉造影证实.术后移植物均可扪及搏动,有28条肢体足背或胫后动脉搏动恢复,17例同时行输入输出道动脉重建术,溃疡清创术6例,4例于术后3天内出现移植物搏动消失,行第2次重建术,结果:ABI平均值同术前0.29上升至0.84,严惩缺血肢体挽救率为100%,经寿命表统计分析,1-5年的血管累积通畅率分别为92%,87%,82%,72%和65%,结论:大隐静脉原位转流术是治疗下肢动脉硬化闭塞症的理想方法之一,同时行输入功输出道动脉重建术,对保证移植血管的通畅有着重要的意义.     

血管腔内介入联合外科手术治疗下肢多节段动脉硬化闭塞症

目的：探讨下肢多节段动脉硬化闭塞症的治疗手段及临床疗效。方法：采用下肢动脉球囊扩张、支架植入结合动脉旁路术、股深动脉成形及原位大隐静脉动脉化,治疗下肢多节段动脉硬化闭塞症31例（36条患肢）,行髂动脉支架植入球囊扩张术33条患肢;股总动脉支架植入球囊扩张术3条患肢,23条患肢行股一胭动脉人工血管旁路术,12条患肢行股深动脉成形术,6条行原位的大隐静脉动脉化。结果：手术均获得成功,未出现严重并发症。术后踝肱指数（0．65±0．18）与术前（0．25±0．11）相比较有明显提高（P〈0．05）。平均随访14个月（2～24个月）,与术前相比,患者术后症状明显好转,跛行距离加大（〉1000m）。结论：下肢动脉腔内介入结合动脉旁路术、股深动脉成形术、大隐静脉动脉化等是治疗多节段多平面下肢动脉硬化闭塞症的有效方法。     

血栓闭塞性脉管炎合并动脉硬化闭塞导致下肢缺血的手术治疗

目的 探讨下肢血栓闭塞性脉管炎(thmmboangiitis obliterans,TAO)合并动脉硬化闭塞症(arteriosclerosis obliterans,ASO)手术治疗效果.方法 回顾性分析2007年治疗的TAO合并ASO 6例患者的资料.2例行腹主动脉切开取栓+内膜剥脱+腹主动脉-股深动脉人工血管旁路移植-胭动脉人工血管-小腿动脉自体大隐静脉旁路移植术,1例行腹主动脉切开取栓+内膜剥脱+腹主动脉-右股深动脉人工血管旁路移植-膝下胭动脉人工血管旁路移植术;1例行左髂总动脉-左股深动脉人工血管旁路移植一胫前动脉自体大隐静脉原位移植术,1例行左侧人工血管切开取栓+左股深动脉成形-膝下腘动脉人工血管旁路移植术,1例行右股总动脉-左股总动脉人工血管旁路移植-胫后动脉自体大隐静脉旁路移植术.结果 5例患者术后恢复顺利,1例于术后当天出现股动脉-腘动脉人工血管和远段的大隐静脉桥血栓形成,立即再次手术行人工血管和大隐静脉切开取栓术,并同时行胫后动静脉吻合.6例患者均痊愈出院,无死亡病例.5例患者的下肢远端静息痛完全缓解,1例部分缓解.足部溃疡的2例创面明显缩小,无感染发生.所有患者得到随访,平均随访为6.5个月,3例足部溃疡愈合.1例术后3个月出现左股部切口感染,最终行膝上截肢处理,残端一期愈合.其他5例患者的移植血管通畅,症状缓解.结论 对TAO合并ASO患者如果手术治疗方式恰当,可以取得比较好的疗效.     

股腘动脉闭塞症的手术治疗

目的 探讨股腘动脉旁路移植术治疗下肢动脉硬化闭塞症(C、D级病变)的近中期疗效.方法 2005年1月至2009年2月,170例患者(191条肢体)行股动脉以远血管重建术.其中男性108例,女性62例;年龄45～85岁,平均67岁.症状包括间歇性跛行78例,静息痛62例,下肢缺血性溃疡19例,远端组织坏死11例.所有患者术前均行动脉造影检查,根据TASC Ⅱ分级:C级病变127条肢体,D级病变64条肢体.手术方法包括大隐静脉原位旁路移植术15条肢体,大隐静脉转位20条肢体,人工血管旁路移植术128条肢体,大隐静脉与人工血管组合旁路移植术28条肢体.结果 围手术期无死亡病例.术后随访6～36个月,平均(24±6)个月;76例失访,随访率57%(109/191).一期通畅率84.4%(92/109),其中人工血管旁路移植通畅率88.2%(75/85),大隐静脉(原位、转位、组合)旁路移植通畅率70.8%(17/24).二期通畅率89.9%(98/109).结论 人工血管旁路移植术是治疗严重股腘动脉闭塞症(TASC C和D级病变)的主要方法,手术疗效满意.     

股深动脉血流重建治疗下肢动脉硬化闭塞症

目的总结股深动脉血流重建治疗下肢动脉硬化闭塞症的经验。方法选择FontaineⅢ、Ⅳ期下肢动脉硬化闭塞症共23例。入选标准：膝上无理想的用于旁路术的流出道，股深动脉主干长度达到或超过股骨干中点且与胭动脉间有侧支血管，近端动脉病变导致股深动脉内无正常动脉血流。采用旁路术、取栓术及股深动脉成形术重建股深动脉血流。结果全部FontaineⅢ期病例于术后肢体静息痛消失；9例FontaineⅣ期病例中术后肢体静息痛消失7例，6例于术后10d行截足（趾）术，1例于术后1周行膝上截肢术。手术后踝／肱血压指数显著增加（P〈0．01）。术后22例随访2个月至6年，移植血管3年通畅率为82％。结论股深动脉血流重建治疗严重肢体缺血简单、安全、有效。     

Long-term follow-up of callotasis lengthening of the capitate after resection of the lunate for the treatment of stage III lunate necrosis

The callotasis lengthening technique was used to gradually lengthen the capitate after resection of the lunate in stage IIIa necrosis in 23 patients. Results of ten patients with a follow-up of at least 5 years showed rapid and sufficient callus formation in every patient regardless of age. The callotasis lengthening modification of the Graner II operation provides all advantages and avoids the major inconvenience of the traditional Graner II operation. There was no increased rate of disturbed fracture healing. Results of the DTPA-gadolinium MRI study did not show any significant impairment of vascularization within the region of the capitate bone. With the “intrinsic bone formation,” contrary to every other intercarpal arthrodesis at the wrist, there is no need for an additional bone graft.     

Magnetic resonance imaging for the evaluation of rejection of a kindney allograft in the rat

Orthotopic DA (RT1^a) into Lewis (RT1¹) rat kidney allografts and control Lewis-into-Lewis grafts were assessed by magnetic resonance imaging (MRI) and perfusion measurement after intravenous injection of a superparamagnetic contrast agent. MRI anatomical scores (range 1–6) and perfusion rates were compared with graft histology (rank of rejection score 1–6). Not only acute rejection, but also chronic events were monitored after acute rejection was prevented by daily cyclosporine (Sandimmune) treatment during the first 2 weeks after transplantation. In acute allograft rejection (n=11), MRI scores reached the maximum value of 6 and perfusion rates were severely reduced within 5 days after transplantation; histology showed severe acute rejection (histologic score 5–6). In the chronic phase (100–130 days after transplantation), allografts (n=5) manifested rejection (in histology cellular rejection and vessel changes), accompanied by MRI scores of around 2–3 and reduced perfusion rates. Both in the acute and chronic phases, the MRI anatomical score correlated significantly with the histological score (Spearman rank correlation coefficient r _s 0.89, n=30, P<0.01), and perfusion rates correlated significantly with the MRI score or histological score (r _s values between-0.60 and -0.87, n=23, P<0.01). It is concluded that MRI represents an interesting tool for assessing the anatomical and hemodynamical status of a kidney allograft in the acute and chronic phases after transplantation.     

Vasoconstrictor effect of cyclosporin on the mesenteric artery in the dog

To evaluate the effect of cyclosporin (CyA) on the mesenteric arterial bed, studies were performed on the isolated mesenteric artery perfused at a constant flow in 20 dogs. Changes in mesenteric perfusion pressure reflected variations in vascular resistance. Pure powder CyA was dissolved in autologous blood and injected at doses of 5, 10, 20 and 40 mg. Infusions of 5 and 10 mg CyA caused nonsignificant mean increases of 3±2 mm Hg [95% confidence interval (CI)-2 to +7; P>0.05] and 3±3 mm Hg (95% CI-3 to +9; P>0.05) in mesenteric perfusion pressure, with CyA blood levels in the mesenteric vein averaging 466±153 and 692±130 nmol/l, respectively, at the end of the injections. Infusions of 20 and 40 mg CyA caused significant increases in mesenteric perfusion pressure averaging 11±3 mm Hg (95% CI 3–18; P<0.05) and 26±4 mm Hg (95 % CI 16–34; P<0.05), respectively. CyA blood levels at the end of infusion averaged 806±85 and 1118±89 nmol/l, respectively, in the mesenteric vein. Blockade of alpha-adrenergic receptors with phentolamine abolished the CyA vasoconstriction of the mesenteric artery, with the increase in perfusion pressure averaging 16±4 mm Hg before and 3±3 mm Hg after phentolamine (P<0.05). Thus, in the dog, CyA causes an acute vasoconstriction of the mesenteric artery through stimulation of alpha-adrenergic receptors.     

The Classic: Hospital for the Cure of Deformities: Course of Lectures on the Deformities of the Human Frame

This Classic Article is a reprint of the original work by W.J. Little, Hospital for the Cure of Deformities: Course of Lectures on the Deformities of the Human Frame. An accompanying biographical sketch of W.J. Little is available at DOI  10.1007/s11999-012-2301-z. The Classic Article is ©1843 and is reprinted courtesy of Elsevier from Little WJ. Hospital for the Cure of Deformities: course of lectures on the deformities of the human frame. Lancet. 1843;41:350–354.     

髋臼重建治疗Crowe Ⅲ型髋臼发育不良

目的 探讨髋臼重建治疗Crowe Ⅲ型髋臼发育不良的手术方法及疗效.方法 2001年1月至2007年6月43例(54髋)Crowe Ⅲ型髋臼发育不良继发骨关节炎患者接受全髋关节置换术治疗.术前Harris评分平均39分.髋臼重建方法包括单纯加深或穿透髋臼(A组)27例(34髋)、髋臼内壁截骨(B组)12例(15髋)、髋臼自体股骨头植骨(C组)4例(5髋).分别记录每种重建方法的手术时间、出血量、并发症.术后随访进行放射学及临床疗效评估.结果 40例(50髋)患者获得完整随访,随访时间平均29个月.在术后3～5个月随访时截骨和植骨已愈合.摄x线片测量A、B、C组重建方式的髋臼外倾角分别为(41.0±7.5)°,(46.0 ±7.7)°,(39.0±11.0)°;前倾角分别为(10.0±2.8)°,(9.0±2.5)°,(4.0±1.9)°;旋转中心上移分别为(8.4±3.6)mm,(7.3 ±2.6)mm,(1.2±0.5)mm;旋转中心内移分别为(7.0±1.5)mm,(9.9 ±1.7)mm,(-2.7 ±1.2)mm.A、B、C组末次随访平均Harris评分分别为B9、91、86分.随访患者中2例发生下肢深静脉血栓,2例可疑肺栓塞,4例坐骨神经麻痹.结论 单纯加深或穿透髋臼、髋臼内壁截骨、自体股骨头植骨是Crowe Ⅲ 型髋臼发育不良髋臼重建的有效方法.应根据术前评估、术中具体情况采用相应的重建方法.     

人工全髋关节置换术治疗强直性脊柱炎髋关节病变的临床疗效

目的 观察人工全髋关节置换治疗强直性脊柱炎髋关节病变的手术方法和临床效果.方法 对2001年3月至2009年6月26例(31髋)强直性脊柱炎髋关节病变患者行人工全髋关节置换并随访,置换前患者日常活动均明显受限或者严重疼痛,Harris评分平均(43.2±5.8)分,髋关节活动度平均51.8°±9.7°.记录术后末次随访的Harris评分,X线检查结果,观察假体有无松动、脱位及异位骨化. 结果 所有病例得到随访,平均随访24.9(8 ～125)个月.末次随访患者均疼痛消失,步态正常.Harris评分平均(82.4±4.7)分;髋关节活动度平均148.6°±7.4°;髋关节Harris评分及关节活动度均显著高于置换前(P＜0.05).2髋出现异位骨化,为Brooker分级Ⅰ、Ⅲ级.无脱位、骨折及假体松动下沉,无患者进行翻修. 结论 人工全髋关节置换是治疗强直性脊柱炎晚期髋关节病变的有效方法,可以恢复关节功能,缓解关节疼痛并改善患者生活质量.     

Genetic requirements for the development of the GVH reaction following small-bowel transplantation

The genetic requirements for the development of graft-versus-host (GVH) disease have been investigated in a model of semiallogenic, heterotopic small-bowel transplantation in the rat. Following semiallogenic MHC-incompatible small-bowel transplantation, all graft recipients showed characteristic signs of GVH disease and died within 14 days. On autopsy the transplanted bowel was normal, while the recipient's bowel was dilated and distended with gas. Histology showed a generalized cell infiltration of the connective tissue with macrophages and lymphocytes. After semiallogenic, RT1.A-incompatible, small-bowel transplantation, the graft recipients developed mild and temporary symptoms of GVH disease between days 25 and 40. Only two of the six animals died, while the remaining animals survived the observation period. Small-bowel transplantation across an isolated RT1.C barrier was unable to induce GVH reaction. These results indicate that the development of GVH disease after small-bowel transplantation is controlled genetically by the MHC. Class II MHC incompatibility is necessary for the induction of an acute and lethal GVH reaction.     

改道性结肠炎治疗进展

改道性结肠炎(diversion colitis,DC)是在结肠或回肠造口术后无粪流通过的旷置结肠段粘膜的非特异性炎症。尽管绝大多数肠道造口患者无症状,但几乎所有粪便改道患者均可出现DC。DC的临床症状主要有腹痛、里急后重、便血以及排粘液分泌物等,且随着肠管旷置时间延长而炎症可日渐加重,进而不同程度影响了这类患者的生活质量。然而,国内对DC的研究甚少,对DC的认识有限,因而还未引起临床医生的足够重视。鉴于此,我们在本文中对DC的表现及治疗方面的研究进展作一综述,以期能够提高临床对改道性结肠炎的认识,同时帮助临床医生做出更好的治疗决策。     

髌骨软骨破坏程度对保留髌骨的全膝关节置换术疗效的影响

目的 探讨髌骨软骨破坏程度对保留髌骨的全膝关节置换术疗效的影响.方法 2002年1月至2006年5月行全膝关节置换术163例244膝,根据术中观察到的髌骨软骨破坏程度将患者分为轻度、中度、重度软骨破坏三组.所有手术均不置换髌骨.术后随访88例133膝,轻度组42膝,中度组43膝,重度组48膝.采用美国膝关节学会评分(Knee Society Score,KSS)系统(包括膝评分和膝功能评分)和膝前痛评分系统对三组疗效进行评估.结果 随访48～102个月,平均72个月.KSS膝评分和膝功能评分从术前(35.1±5.4)分和(19.2±9.8)分分别提高到(91.7±5.6)分和(83.7±17.5)分.三组KSS膝评分从术前(34.7±6.2)分、(36.5±5.2)分、(35.3±6.2)分分别提高至(92.6±4.5)分、(90.5±6.7)分、(91.9±5.9)分;膝功能评分从术前(14.2±8.6)分、(16.5±7.4)分、(17.0±7.5)分分别提高至(86.6±12.6)分、(82.0±17.2)分、(82.8±21.1)分.三组术后膝评分和膝功能评分的差异均无统计学意义.术后膝前痛的发生率为11.3%(15/133),轻度、中度、重度软骨破坏组分别为11.9%(5/42)、11.6%(5/43)、10.4%(5/48),差异无统计学意义.结论 全膝关节置换术后疗效及膝前痛的发生率与术前髌骨软骨破坏程度无关,髌骨软骨破坏程度不是全膝关节置换术中置换髌骨的可靠依据.

Abstract：

Objective To determine whether there was any correlation between the degree of degenerative changes in the patellar cartilage and the clinical outcome after TKA without patellar resurfacing.Methods A clinical study was performed on 133 knees of 88 patients that underwent TKA without patellar resurfacing from January 2002 to May 2006. According to the degenerative condition of the patellar cartilage,patients was classified as mild group, moderate group, and severe group. Pre- and post-operative evaluations were performed using the knee and function scores of the Knee Society Clinical Rating System (KSS) and Anterior Knee Pain Rating. Results The duration of follow-up was 72 months (range 48-102). The overall knee score of KSS in all patients were improved from 35.1±5.4 preoperatively to 91.7±5.6 postoperatively,and function score of KSS from 19.2±9.8 preoperatively to 83.7±17.5 postoperatively. The mean knee scores of KSS were improved from 34.7±6.2, 36.5±5.2 and 35.3±6.2 preoperatively to 92.6±4.5, 90.5±6.7 and 91.9±5.9 in mild, moderate, and severe group postoperatively, respectively. The mean function scores of KSS were improved from 14.2±8.6, 16.5±7.4 and 17.0±7.5 postoperatively to 86.6±12.6, 82.0±17.2 and 82.8±21.1 in mild, moderate, and severe group postoperatively, respectively. There was no difference among all groups with regard to the postoperative knee scores and function scores of KSS. The prevalence of anterior knee pain was 11.3% in all, and 11.9% in mild group, 11.6% in moderate group and 10.4% in severe group. There was no difference among all groups with regard to the anterior knee pain. Conclusion The clinical outcome and anterior knee pain after TKA without patellar resurfacing was not correlated with the severity of degenerative changes in the patellar cartilage. The degree of degenerative condition of the patellar cartilage is not indication for patellar resurfacing.